Similar articles for PMID: 28655806

Year	Number of Results
1971	1
1977	1
1984	2
1988	2
1991	1
1992	3
1993	3
1994	7
1995	3
1996	7
1997	5
1998	2
1999	3
2000	1
2001	1
2002	1
2003	1
2004	1
2010	1
2012	2
2013	3
2014	1
2015	3
2016	4
2017	6
2018	3
2019	2
2021	0

1

Cost of Contraceptive Implant Removal Services Must Be Considered When Responding to the Growing Demand for Removals.

Sergison JE, Stalter RM, Callahan RL, Rademacher KH, Steiner MJ. Sergison JE, et al. Glob Health Sci Pract. 2017 Jun 27;5(2):330-332. doi: 10.9745/GHSP-D-17-00100. Print 2017 Jun 27. Glob Health Sci Pract. 2017. PMID: 28655806 Free PMC article. No abstract available.

2

Cost-effectiveness of levonorgestrel subdermal implants. Comparison with other contraceptive methods available in the United States.

Ashraf T, Arnold SB, Maxfield M Jr. Ashraf T, et al. J Reprod Med. 1994 Oct;39(10):791-8. J Reprod Med. 1994. PMID: 7837126

3

Norplant removals vital to quality care.

Barnett B. Barnett B. Netw Res Triangle Park N C. 1995 Jun;15(4):21-5. Netw Res Triangle Park N C. 1995. PMID: 12289830

4

Extended use up to 5 years of the etonogestrel-releasing subdermal contraceptive implant: comparison to levonorgestrel-releasing subdermal implant.

Ali M, Akin A, Bahamondes L, Brache V, Habib N, Landoulsi S, Hubacher D; WHO study group on subdermal contraceptive implants for women. Ali M, et al. Hum Reprod. 2016 Nov;31(11):2491-2498. doi: 10.1093/humrep/dew222. Epub 2016 Sep 26. Hum Reprod. 2016. PMID: 27671673 Free PMC article. Clinical Trial.

5

Levonorgestrel subdermal implants. Contraception on trial.

Frank ML, DiMaria C. Frank ML, et al. Drug Saf. 1997 Dec;17(6):360-8. doi: 10.2165/00002018-199717060-00002. Drug Saf. 1997. PMID: 9429835 Review.

6

Prospective multicentre study comparing levonorgestrel implants with a combined contraceptive pill: final results.

Kirkman RJ, Bromham DR, O'Connor TP, Sahota JE. Kirkman RJ, et al. Br J Fam Plann. 1999 Jul;25(2):36-40. Br J Fam Plann. 1999. PMID: 10454652 Clinical Trial.

7

Two-year continuation of intrauterine devices and contraceptive implants in a mixed-payer setting: a retrospective review.

Sanders JN, Turok DK, Gawron LM, Law A, Wen L, Lynen R. Sanders JN, et al. Am J Obstet Gynecol. 2017 Jun;216(6):590.e1-590.e8. doi: 10.1016/j.ajog.2017.02.003. Epub 2017 Feb 8. Am J Obstet Gynecol. 2017. PMID: 28188772 Free PMC article.

8

The Levonorgestrel Intrauterine System: A Pragmatic View of an Excellent Contraceptive.

Jacobstein R, Shelton JD. Jacobstein R, et al. Glob Health Sci Pract. 2015 Oct 28;3(4):538-43. doi: 10.9745/GHSP-D-15-00330. Glob Health Sci Pract. 2015. PMID: 26681702 Free PMC article.

9

Public funding and policies for provision of the contraceptive implant, fiscal year 1992.

Kaeser L. Kaeser L. Fam Plann Perspect. 1994 Jan-Feb;26(1):11-6. Fam Plann Perspect. 1994. PMID: 8174690

10

Risks and benefits, advantages and disadvantages of levonorgestrel-releasing contraceptive implants.

Sivin I. Sivin I. Drug Saf. 2003;26(5):303-35. doi: 10.2165/00002018-200326050-00002. Drug Saf. 2003. PMID: 12650633 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed